If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Angelo Delmonte is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mutation Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 926 Citations
  • 17 h-Index
  • 60 Article
  • 1 Editorial
  • 1 Letter

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., Nov 21 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 1 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Immunotherapy
Neoplasm Metastasis
Bone and Bones
Disease-Free Survival
1 Citation (Scopus)

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience

Rihawi, K., Giannarelli, D., Galetta, D., Delmonte, A., Giavarra, M., Turci, D., Garassino, M., Tiseo, M., Barbieri, F., Panni, S. & Ardizzoni, A., Mar 2019, In : Journal of Thoracic Oncology. 14, 3, p. e57-e59

Research output: Contribution to journalLetter

3 Citations (Scopus)

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 others, Turci, D. & Galetta, D., Jan 8 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Mutation
National Cancer Institute (U.S.)
Terminology
Disease-Free Survival

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 others, Turci, D. & Galetta, D., 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Crinò, L., Bidoli, P., Delmonte, A., Grossi, F., De Marinis, F., Ardizzoni, A., Vitiello, F., Lo Russo, G., Parra, H. S., Cortesi, E., Cappuzzo, F., Calabrò, L., Tiseo, M., Turci, D., Gamucci, T., Antonelli, P., Morabito, A., Chella, A., Giannarelli, D. & Galetta, D., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Population
Survival
Controlled Clinical Trials
docetaxel